Abstract
We report a case of Crohn's disease (CD) of new onset in a patient being treated with tacrolimus for the prevention of renal allograft rejection. Tacrolimus is a calcineurin inhibitor used as a first-line immunosuppressive drug in organ transplant recipients to prevent allograft rejection. Recent reports also suggest a role for the drug in the treatment of CD. This case reports the onset of CD in a patient already on a potent immunosuppressive regimen. Such cases of new onset CD and CD refractory to immunosuppressive therapy support the idea that the pathogenicity of this disease is multifactorial involving multiple arms of the immune response.
| Original language | English |
|---|---|
| Pages (from-to) | 70-78 |
| Number of pages | 9 |
| Journal | Practical Gastroenterology |
| Volume | 30 |
| Issue number | 11 |
| State | Published - Nov 2006 |
| Externally published | Yes |